Evidence map›Paper›PMID 39958939›Full record

ArticleJournal of pharmaceutical policy and practice2025

Barriers to effective communication in UAE community pharmacies: general public perspectives on enhancing patient-pharmacist interaction and policy development.

Zelal Kharaba, Ahmad Al-Azayzih, Sayer Al-Azzam, Anan Jarab, Hisham E Hasan, Dania Rahhal, Feras Jirjees, Khalid A Al-Kubaisi, Monia H Aljumah, Faris El-Dahiyat and 4 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zelal KharabaDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0001-8012-684X
Ahmad Al-AzayzihDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0001-8426-0034
Sayer Al-AzzamDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Anan JarabDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.ORCID https://orcid.org/0000-0002-0416-506X
Hisham E HasanDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Dania RahhalDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
Feras JirjeesDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0001-6265-0808
Khalid A Al-KubaisiDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
Monia H AljumahDepartment of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
Faris El-DahiyatDepartment of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.ORCID https://orcid.org/0000-0002-5264-8699
Sara MeerDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
Mohammad A Y AlqudahDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
Mamoon A AldeyabDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UK.ORCID https://orcid.org/0000-0001-8148-7612
Karem H AlzoubiDepartment of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0002-2808-5099

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community pharmacies serve as accessible points of care, offering essential services such as medication dispensing, health consultations, vaccinations, and chronic disease management, thereby playing a critical role in the healthcare system. This study aims to identify and evaluate the factors that obstruct general public-pharmacist interactions, providing insights to enhance pharmacy environments. Methods: A total of 406 general publics were surveyed using a validated questionnaire. Statistical analysis was performed with categorical variables presented as frequencies and percentages, and continuous variables as medians with 95% confidence intervals. Binary regression models were used to explore the relationships between sociodemographic characteristics and communication barriers, with a significance level set at Results: The primary reasons for pharmacy visits were collecting prescription medications (61.58%) and purchasing OTC products (55.17%), while health screenings were less common (9.11%). Barriers to effective communication included crowded environments (61.58%), limited counseling time (45.81%), and lack of privacy (45.07%). Binary logistic regression revealed that participants who visited the pharmacy weekly were 5.5 times more likely to experience high environmental barriers (OR: 5.502, Conclusion: Effective communication is crucial in community pharmacies for high-quality healthcare. This study identifies key barriers in the UAE and offers insights into targeted interventions to improve communication and public satisfaction.

Indexed as

Community pharmacyeffective communicationenvironmental barrierspersonal barrierspharmacy servicesUnited Arab Emirates

Identifiers

PMID39958939
PMCPMC11827033

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.